Energy and construction materials company MDU Resources (NYSE:MDU) reported Q3 CY2025 revenues of $315.1 million, exceeding the market’s revenue expectations. Its GAAP profit of $0.09 per share decreased from $0.32 in the same quarter last year.
Agricultural and farm machinery company Titan (NSYE:TWI) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 4.1% year on year to $466.5 million. On the other hand, next quarter’s revenue guidance of $397.5 million was less impressive, coming in 5.5% below analysts’ estimates. Its GAAP loss of $0.04 per share was $0.01 below analysts’ consensus estimates.
Hospitality company Hyatt Hotels (NYSE:H) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 9.6% year on year to $1.79 billion. Its non-GAAP loss of $0.30 per share was significantly below analysts’ consensus estimates.
Cloud software provider Upland Software (NASDAQ:UPLD) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales fell by 24.2% year on year to $50.53 million. On the other hand, next quarter’s revenue guidance of $49.4 million was less impressive, coming in 2.7% below analysts’ estimates. Its non-GAAP profit of $0.30 per share was 73.1% above analysts’ consensus estimates.
Private markets investment firm P10 (NYSE:PX) fell short of the markets revenue expectations in Q3 CY2025 as sales rose 2.2% year on year to $75.9 million. Its non-GAAP profit of $0.24 per share was in line with analysts’ consensus estimates.
Global entertainment and media company Warner Bros. Discovery (NASDAQ:WBD) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 6% year on year to $9.05 billion. Its GAAP loss of $0.06 per share was $0.03 above analysts’ consensus estimates.
Blood products company Haemonetics (NYSE:HAE). reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 5.3% year on year to $327.3 million. Its non-GAAP profit of $1.27 per share was 14.3% above analysts’ consensus estimates.
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 billion, close to analysts’ estimates. Its non-GAAP profit of $0.75 per share was 15.6% above analysts’ consensus estimates.
